Stonepine Capital Management, LLC Quant / Systematic

Location: Bend, OR

CIK: 0001440771 · Show all filings

Period: Q2 2016 (← Previous) (Next →)

Filing Date: Aug 11, 2016

Total Value: $97.54M (88.5% shares, 11.5% debt)

Holdings (23)

SCICLONE PHARMACEUTICALS INC 14.5%
Value $14.14M Shares 1,082,532 Est. Cost $9.97 Unrealized
Viveve Medical, Inc 10.9%
Value $10.66M Shares 2,599,711 Est. Cost $4.10 Unrealized
Aegerion Pharmaceuticals, Inc. (NOTES) 10.1%
Value $9.861M Shares 17,300,000 Est. Cost $0.57 Unrealized
VNDA VANDA PHARMACEUTICALS INC 9.3%
Value $9.081M Shares 811,563 Est. Cost $9.85 Unrealized -1.7%
TOBIRA THERAPEUTICS INC 8.2%
Value $8.008M Shares 637,567 Est. Cost $10.05 Unrealized
PAIN THERAPEUTICS INC 6.4%
Value $6.215M Shares 2,837,878 Est. Cost $1.75 Unrealized
QLT Inc. 5.5%
Value $5.367M Shares 3,779,274 Est. Cost $1.42 Unrealized
SAGENT PHARMACEUTICALS INC 5.5%
Value $5.337M Shares 356,307 Est. Cost $15.85 Unrealized
VCEL VERICEL CORP 5.2%
Value $5.063M Shares 2,250,000 Est. Cost $2.48 Unrealized +16.0%
CUTERA INC 5.0%
Value $4.91M Shares 438,000 Est. Cost $11.59 Unrealized
RECRO PHARMA INC 3.5%
Value $3.408M Shares 428,670 Est. Cost $7.68 Unrealized
Alere Inc. 3.2%
Value $3.126M Shares 75,000 Est. Cost $41.68 Unrealized
Sucampo Pharmaceuticals, Inc. 2.4%
Value $2.346M Shares 213,860 Est. Cost $10.97 Unrealized
PCRX Pacira Pharmaceuticals, Inc. 1.8%
Value $1.759M Shares 52,157 Est. Cost $49.15 Unrealized 0.0%
PERNIX THERAPEUTICS HOLDINGS 1.4%
Value $1.38M Shares 6,000,000 Est. Cost $0.23 Unrealized
Flamel Technologies SA 1.4%
Value $1.375M Shares 128,005 Est. Cost $10.74 Unrealized
BioSpecifics Technologies Corp. 1.2%
Value $1.198M Shares 30,000 Est. Cost $35.57 Unrealized
Enanta Pharmaceuticals, Inc. 1.2%
Value $1.16M Shares 52,616 Est. Cost $22.05 Unrealized
DERMA SCIENCES INC 1.1%
Value $1.116M Shares 283,306 Est. Cost $4.57 Unrealized
VCYT Veracyte, Inc. 1.0%
Value $940K Shares 186,926 Est. Cost $5.36 Unrealized 0.0%
CPIX Cumberland Pharmaceuticals, Inc. 0.6%
Value $580K Shares 128,798 Est. Cost $4.58 Unrealized 0.0%
Aviragen Therapeutics, Inc. 0.4%
Value $412K Shares 294,269 Est. Cost $1.40 Unrealized
DURECT Corporation 0.1%
Value $98,000 Shares 80,160 Est. Cost $1.22 Unrealized